Well Oz, it got me wondering when all the other midkine related patents might expire...
As for PEB, they might be lucky because in answer to a question, one of the Directors said they did have one competitor in their space with a test for Bladder Cancer - but for some reason they withdrew their test....leaving PEB as the only current player in the market. He also said they have a few years head start on any others who might be trying to create a test. Remember also that PEB has at least 4 tests in their CxBladder suite of products.
PacificEdge update, page-184
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $3.691M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.8¢ | $8.671K | 1.051M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1735002 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 340000 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |